Skip to main content

Rybelsus® vs. Placebo as Add-on to Insulin (PIONEER 8 Study)

This video discusses the trial-design and outcomes of the PIONEER 8 study. PIONEER 8 was a 52-week, phase 3a, randomized, double-blind, parallel-group, multinational trial enrolling 731 adults with type 2 diabetes.

Play
Pause
Skip
Volume
Chapters
Transcript
References
video_su
Fullscreen

Rybelsus® vs. Placebo as Add-on to Insulin (PIONEER 8 Study)

Chapters
Transcript
References

Return to overview

Transcripts

Return to overview

References